MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Extrapyramidal involvement in amyotrophic lateral sclerosis: results of a prospective population-based study

M. Rizzone, F. Dematteis, A. Chiò, S. Cammarosano, C. Artusi, M. Pagani, F. Nobili, A. Cistaro, M. Balma, E. Montanaro, B. Iazzolino, A. Canosa, L. Lopiano, A. Calvo (Torino, Italy)

Meeting: 2017 International Congress

Abstract Number: 201

Keywords: Amyotrophic lateral sclerosis, Positron emission tomography(PET)

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To assess frequency, clinical characteristics and functional neuroimaging correlates of parkinsonian signs in a population-based series of new-diagnosed amyotrophic lateral sclerosis (ALS) patients.

Background: Parkinsonian signs in ALS patients have been reported in few papers, and their pathophysiological correlates are largely unknown.

Methods: ALS patients resident in Piemonte, Italy, diagnosed during 2013 were eligible to participate in the study. All patients were evaluated by two neurologists expert in movement disorders to detect the presence of parkinsonian signs (ALS-P) at diagnosis, 1 and 2 years. Patients underwent genetic tests and neuropsychological examination, and severity of parkinsonian symptoms was rated by MDS-UPDRS. DaTSCAN® SPECT was analysed visually and semiquantitavely and FDG-PET was compared between patients with or without parkinsonian signs by means of SPM8.

Results: Out of a total of 114 eligible ALS patients, 101 (64 men and 37 women; mean age at onset of 65.1 ± 11.7 years) were recruited. Twenty-eight patients (27.7%) were classified as ALS-P at the first visit. MDS-UPDRS scores were higher in ALS-P than ALS patients, in particular ALS-P patients showed more serious bradykinesia, rigidity and tremor (p<0,05). ALS-P patients were more frequently male (relative risk 1.36, c.i. 1.04-1.80; p=0.05). Age and site of onset, cognitive impairment, ALSFRS-R and MRC scores, genetics and survival were similar in ALS and ALS-P patients. Both visual and semi-quantitative analysis of DaTSCAN® revealed a normal scan in all but two ALS-P patients. On FDG-PET, ALS-P patients showed lower FDG uptake in left cerebellum and a relatively more preserved metabolism in right insula and in some right frontal regions compared to ALS patients.

Conclusions: In this population-based study more than one fourth of ALS patients showed parkinsonian signs. In ALS-P patients no significant nigrostriatal involvement could be demonstrated. Instead, relative hypometabolism in the left cerebellar hemisphere together with more preserved right prefrontal metabolism were found. These data suggest the involvement of brain circuitries other than classical nigrostriatal ones in ALS patients with parkinsonian signs.

To cite this abstract in AMA style:

M. Rizzone, F. Dematteis, A. Chiò, S. Cammarosano, C. Artusi, M. Pagani, F. Nobili, A. Cistaro, M. Balma, E. Montanaro, B. Iazzolino, A. Canosa, L. Lopiano, A. Calvo. Extrapyramidal involvement in amyotrophic lateral sclerosis: results of a prospective population-based study [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/extrapyramidal-involvement-in-amyotrophic-lateral-sclerosis-results-of-a-prospective-population-based-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/extrapyramidal-involvement-in-amyotrophic-lateral-sclerosis-results-of-a-prospective-population-based-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley